معرفی
Linda Beauclair, MD, FRCPC is an Assistant Professor in the Department of Psychiatry at McGill University's Faculty of Medicine and Health Sciences. She serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) and is affiliated with the Brain Repair and Integrative Neuroscience (BRaIN) Program.
Dr. Beauclair's research focuses on psychopharmacology and clinical trials related to schizophrenia treatment. Her primary areas of interest include:
- Antipsychotics and their mechanisms
- Treatment of negative symptoms in schizophrenia
- Long-acting injectable antipsychotic medications
- Pharmacogenetics in psychiatric treatment
- Anticholinergic treatments and movement disorders
- Generic versus brand-name psychotropic medications
Her publication record spans multiple decades with recent work in 2023-2024 showing expansion into cellular mechanisms related to psychiatric conditions alongside her ongoing clinical research in schizophrenia treatment. Dr. Beauclair has published extensively on antipsychotic medications, particularly examining efficacy, tolerability, comparative effectiveness, and pharmacogenetic aspects of different treatment approaches. Her research often involves multicenter randomized clinical trials investigating new add-on treatments for patients with persistent negative symptoms of schizophrenia, with optional DNA specimen collection for pharmacogenetic analysis.
As an active researcher within the RI-MUHC, Dr. Beauclair contributes to advancing treatment options for schizophrenia patients through rigorous clinical investigation and translational research connecting molecular mechanisms with clinical outcomes.
